Skip to main content

TableĀ 1 Comparison of both groups regarding baseline features, comorbidities, ABG, PFT, HRCT, and ECHO

From: Study of the prevalence and predictive factors of sleep-disordered breathing in patients with interstitial lung diseases

Variable

Overall

Without OSA

With OSA

p-value

Patient, no

69

45 (65.2%)

24 (34.8%)

Ā 

Age (years)

53.1ā€‰Ā±ā€‰14.2

50.1ā€‰Ā±ā€‰14.5

58.6ā€‰Ā±ā€‰12.2

0.01*

Weight (kg)

73.5ā€‰Ā±ā€‰19.4

70.5ā€‰Ā±ā€‰20.2

79.04ā€‰Ā±ā€‰16.7

0.08

Height (cm)

158.4ā€‰Ā±ā€‰11.8

155.6ā€‰Ā±ā€‰10.7

163.6ā€‰Ā±ā€‰12.3

0.006**

BMI (kg/m2)

29.2ā€‰Ā±ā€‰7

28.8ā€‰Ā±ā€‰7.2

29.8ā€‰Ā±ā€‰6.7

0.6

Neck circumference (cm)

39.1ā€‰Ā±ā€‰4.3

38.4ā€‰Ā±ā€‰3.8

40.5ā€‰Ā±ā€‰4.8

0.07

Sex

ā€ƒMale

13 (18.8%)

5 (38.50%)

8 (61.50%)

0.04*

ā€ƒFemale

56 (81.2%)

40 (71.40%)

16 (28.60%)

Occupation

ā€ƒNot working males

3 (4.30%)

2 (66.70%)

1 (33.30%)

0.8

ā€ƒHousewife

43 (62.40%)

29 (67.40%)

14 (32.60%)

ā€ƒWorking

23 (33.30%)

14 (60.90%)

9 (39.10%)

Smoking/biomass exposure

ā€ƒNon-smoker

18 (26.10%)

12 (66.70%)

6 (33.30%)

0.1

ā€ƒSmoking

7 (10.1%)

2 (28.6%)

5 (71.4%)

ā€ƒBiomass exposure

44 (63.8%)

31 (70.5%)

13 (29.50%)

ABG

ā€ƒPH

7.4ā€‰Ā±ā€‰0.04

7.4ā€‰Ā±ā€‰0.05

7.4ā€‰Ā±ā€‰0.03

0.3

ā€ƒPaO2

74.7ā€‰Ā±ā€‰12.8

73.8ā€‰Ā±ā€‰12.6

76.4ā€‰Ā±ā€‰13.3

0.4

ā€ƒPaCO2

39.7ā€‰Ā±ā€‰13.1

38.7ā€‰Ā±ā€‰13.4

41.6ā€‰Ā±ā€‰12.6

0.3

ā€ƒSaO2%

93.6ā€‰Ā±ā€‰3.4

93.4ā€‰Ā±ā€‰3.5

93.8ā€‰Ā±ā€‰3.3

0.6

ā€ƒCRP

29.9ā€‰Ā±ā€‰42.4

25.1ā€‰Ā±ā€‰34

38.8ā€‰Ā±ā€‰54.5

0.2

Pulmonary function

ā€ƒFEV1/FVC

73.4ā€‰Ā±ā€‰13.9

72.3ā€‰Ā±ā€‰14.7

75.6ā€‰Ā±ā€‰12.1

0.3

ā€ƒFEV1%

49.3ā€‰Ā±ā€‰20

49.4ā€‰Ā±ā€‰22.7

49.3ā€‰Ā±ā€‰14.1

0.9

ā€ƒFVC%

53.2ā€‰Ā±ā€‰22.9

56.4ā€‰Ā±ā€‰26.3

47.1ā€‰Ā±ā€‰13.1

0.1

ā€ƒSpO2 on RA

87.1ā€‰Ā±ā€‰8.6

86.9ā€‰Ā±ā€‰9.6

87.6ā€‰Ā±ā€‰6.6

0.7

ā€ƒ6MWD (m)

183.4ā€‰Ā±ā€‰113.7

193.3ā€‰Ā±ā€‰111.8

164.8ā€‰Ā±ā€‰117.5

0.3

Interstitial lung disease

ā€ƒGGO

46 (66.7%)

29 (60.9%)

17 (39.1%)

0.4

ā€ƒAir trapping

27 (39.1%)

18 (66.7%)

9 (33.3%)

0.9

ā€ƒHoneycombing

14 (20.3%)

7 (50%)

7 (50%)

0.2

ā€ƒReticulations

42 (60.9%)

25 (59.5%)

17 (40.5%)

0.3

ā€ƒNodular

4 (5.8%)

2 (50%)

2 (50%)

0.6

ā€ƒCystic

4 (5.8%)

3 (75%)

1 (25%)

1

Possible etiology

ā€ƒHP

44 (63.8%)

31 (70.5%)

13 (29.5%)

0.3

ā€ƒCTD-ILD

8 (11.6%)

6 (75%)

2 (25%)

ā€ƒIPF

15 (21.7%)

7 (46.7%)

8 (53.3%)

ā€ƒSarcoidosis

2 (2.9%)

1 (50%)

1 (50%)

Comorbidities

ā€ƒDM

13 (18.8%)

5 (46.20%)

8 (53.80%)

0.2

ā€ƒHTN

15 (21.7%)

9 (60%)

6 (40%)

0.8

Echo findings

ā€ƒEF%

66.03ā€‰Ā±ā€‰4.9

66.7ā€‰Ā±ā€‰4.4

64.3ā€‰Ā±ā€‰5.4

0.03*

ā€ƒLt atrium diameter (mm)

3.4ā€‰Ā±ā€‰0.35

3.2ā€‰Ā±ā€‰0.31

3.5ā€‰Ā±ā€‰0.33

0.001**

ā€ƒEPASP (mmHg)

42.6ā€‰Ā±ā€‰23

44.6ā€‰Ā±ā€‰25.9

38.8ā€‰Ā±ā€‰15.9

0.3

Degree of PHT

ā€ƒNo

38 (55.2%)

24 (63.2%)

14 (36.8%)

0.3

ā€ƒMild (40ā€“50)

9 (13%)

4 (44.4%)

5 (55.6%)

ā€ƒModerate (51ā€“60)

11 (15.9%)

8 (72.7%)

3 (27.3%)

ā€ƒSevere(>ā€‰60)

11 (15.9%)

9 (81.8%)

2 (18.2%)

RT ventricle

ā€ƒNormal

47 (68.1%)

29 (61.7%)

18 (38.2%)

0.4

ā€ƒDilated

22 (31.9%)

16 (72.7%)

6 (27.3%)

  1. BMI body mass index, PaO2 partial pressure of oxygen, PaCO2 partial pressure of carbon dioxide, SaO2 oxygen saturation, CRP C-reactive protein, FEV1 forced expiratory volume in first second, FVC forced vital capacity, 6MWD 6-min walk distance, GGO ground glass opacification, HP hypersensitivity pneumonitis, CTD connective tissue disease, IPF idiopathic pulmonary fibrosis, DM diabetes mellitus, HTN hypertension, EF ejection fraction, EPASP estimated pulmonary artery systolic pressure, OSA obstructive sleep apnea, significant p-value of 0.05 or less